![](/img/cover-not-exists.png)
763 Clinical impact of the dose modification of second-line targeted therapy for patients with metastatic renal cell carcinoma
Shirotake, S., Yasumizu, Y., Tanaka, N., Mizuno, R., Ito, Y., Miyazaki, Y., Masunaga, A., Ito, K., Hagiwara, M., Asano, T., Oya, M., Oyama, M.Volume:
15
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(16)60765-0
Date:
March, 2016
File:
PDF, 200 KB
english, 2016